CCL2 was also observed to decrease with age in the total cohort by both robust linear regression and Spearman correlation, but increases in the ME/CFS cohort with increasing age, according to Spearman correlation (Fig. 6d, Table 3). The gene discussed is CCL2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.